Drug Discovery World

What Drug Discovery World does

Drug Discovery World (DDW) is a UK-based, privately held B2B media brand operated by Edify Digital Media Ltd (headquartered in Tunbridge Wells, Kent), targeting the global drug discovery and pharmaceutical research community. The company describes itself as the 'multi-platform global voice for the drug discovery community' and covers the drug development pipeline from research stage through Phase I/II clinical trials, spanning scientific and commercial content including target identification, lead optimisation, regulatory changes, and biotech investment trends.

The company's product portfolio spans a website (ddw-online.com), a quarterly printed and digital magazine (with archive from Spring 2020), a weekly e-newsletter, four monthly themed newsletters (AI & Lab Automation, Spatial Biology, Cell & Gene Therapy, Neuroscience), DDW eBooks, free webinars and roundtables, the DDW Highlights podcast (launched 2025), market reports, trends & analysis, a Resources area for third-party whitepapers, and the DDII Events Series (Drug Discovery Innovators & Investors UK Conference). The underlying technology is a standard digital publishing platform with multi-channel content distribution; no proprietary AI, API, or SDK capabilities are disclosed. There is no mobile app.

DDW operates a freemium reader model — all content is free to registered members — and monetises exclusively through advertising and sponsorship sold to pharmaceutical, biopharmaceutical, and biotech sector advertisers (named sponsors include Emulate, Sartorius, and Evotec). The go-to-market is direct-to-consumer for reader acquisition (free registration) combined with event-driven demand generation (DDII conferences, webinars). The company is privately held with 1–10 employees, no disclosed funding rounds, and no evidence of external investment. Leadership comprises Managing Director Maria Wallace, Publishing Director Lu Rahman, Editor Reece Armstrong, Deputy Editor Diana Turner, Head of Sales Rich York, and Sales Manager Christine Joinson.

Name

Drug Discovery World

Legal name

Edify Digital Media Ltd

Website

https://ddw-online.com

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

1–10 employees

Short description

Drug Discovery World is a UK-based B2B media brand covering the global drug discovery and pharmaceutical research pipeline through a website, quarterly magazine, newsletters, podcasts, webinars, eBooks, and events, monetised via advertising and sponsorship from pharma and biotech firms.

Ownership category

akta.pro rank

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Digital Commerce or Content

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Advertising & Sponsorship: DDW generates revenue primarily through advertising and sponsorship opportunities offered to pharmaceutical, biotech, and life sciences companies wanting to reach the drug discovery professional community. The Media Info page explicitly invites advertising and sponsorship enquiries.
2. Sponsored Content & eBooks: DDW produces sponsored eBooks and educational resources (such as those from Emulate, Sartorius, Evotec, etc.) that generate sponsorship revenue while providing value to the reader community.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels8 records

Core offering

Drug Discovery World (DDW) operates a multi-platform B2B media brand serving the global drug discovery community. It publishes news, features, market reports, and expert analysis covering the scientific and commercial process of bringing drugs to market, distributed through a website, quarterly digital/print magazine, email newsletters, webinars, podcasts, eBooks, and in-person industry conferences.

Product overview

Drug Discovery World (DDW) operates as a multi-platform media and intelligence brand for the drug discovery community. The core offering consists of the DDW Website/Online Platform providing comprehensive coverage from research stage through clinical trials, complemented by the quarterly DDW Digital Magazine. The product portfolio includes content delivery modules: the DDW Weekly E-newsletter and monthly themed e-newsletters (AI & Lab Automation, Spatial Biology, Cell & Gene Therapy, Neuroscience); DDW eBooks offering premium authored reports; DDW Webinars and DDW Podcasts (including the DDW Highlights series) for multimedia content; and the DDII Events Series for in-person industry conferences. Additional intelligence products include Market Reports and Trends & Analysis. Membership provides free access to these resources, with the digital magazine available from Spring 2020 onwards and previous years' content accessible in the Archive section.

Differentiator

Problem solved

Functional benefit

Products and services

• DDW Online Platform (ddw-online.com) The primary multi-platform online presence for the global drug discovery community, providing free member access to news, features, exclusive content, market reports, trends and analysis, the Start-up Zone, webinars, videos, and podcasts covering the scientific and commercial process of getting drugs to market.
• DDW Digital Magazine A quarterly printed and digital publication for drug discovery professionals, covering research, target identification, drug molecule identification, lead optimisation, pre-clinical research, clinical trials, and the commercial process of turning science into business. Current and previous editions (from Spring 2020) are accessible to free members.
• DDW Weekly E-newsletter A free weekly email roundup of the most interesting and pertinent drug discovery industry news and developments, delivered to registered members.
• DDW Monthly Themed E-newsletters Monthly themed e-newsletters covering dedicated drug discovery topics including AI & Lab Automation, Spatial Biology, Cell & Gene Therapy, and Neuroscience, available to registered members.
• DDW eBooks Premium DDW-authored eBooks and eReports available as free downloads for members, covering specialized drug discovery topics including vaccines, virology, cancer research, cell and gene therapy, AI, lab automation, neuroscience, and antibody-drug conjugates.
• DDW Webinars Free-to-access editorial and custom webinars, roundtables, and DDW Summits featuring drug discovery industry experts, often supported by third-party sponsors.
• DDW Podcasts (DDW Highlights) Multimedia audio content including the DDW Highlights podcast series, hosted by Megan Thomas and Bruno Quinney, narrating key drug discovery industry stories to update subscribers on recent trends.
• DDII Events Series (Drug Discovery Innovators & Investors) The Drug Discovery Innovators & Investors UK Conference, an in-person industry event bringing together R&D leaders, lab managers, pharma/biotech decision-makers, researchers, start-ups, and investors to discuss key challenges in drug development.
• Market Reports In-depth market analysis and reporting covering the pharmaceutical, biopharmaceutical, and biotech sectors, including investment trends, company rankings, and sector performance.

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Edify Digital Media LtdcoreOthersEdify Digital Media Ltd is the parent company and publisher of Drug Discovery World. DDW operates as a brand under Edify Digital Media, with Maria Wallace serving as Managing Director, Lu Rahman as Publishing Director, and other team members affiliated through the parent company.

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• BioWorld: Subscription-based pharma intelligence publication (part of Clarivate) covering drug development and clinical advances; overlaps DDW on drug discovery news and competes for the same pharma/biopharma decision-maker audience, albeit with a heavier paid-data model.
• BioPharma Dive: B2B news and analysis publication covering biopharma industry news, pipelines, and deal flow; competes with DDW for pharma/biotech professional readership and advertiser demand in a similar digital-first format.
• The Pharma Letter: Long-running international B2B pharmaceutical news publication covering drug development, regulatory affairs, and commercial topics; comparable to DDW in targeting pharmaceutical professionals globally with editorial plus paid promotion.
• BioCentury: Long-established B2B intelligence publication covering biotech and drug development from discovery through clinical and commercial stages — directly comparable to DDW in audience (pharma/biotech R&D leaders and investors) and revenue model (subscriptions and sponsorships).
• Endpoints News: Daily B2B news outlet focused exclusively on the biopharma and drug development industry; competes with DDW for the same pharma/biopharma executive and investor readership and the same pharmaceutical company advertising and sponsorship dollars.
• Fierce Pharma: Flagship B2B pharma publication from Questex covering commercial, regulatory, and R&D news across the pharma value chain; competes with DDW for pharma executive readership and pharmaceutical company advertising/sponsorship spend.
• Genetic Engineering & Biotechnology News (GEN): Long-running B2B trade publication covering biotechnology and drug discovery technologies; comparable to DDW in targeting bench scientists and R&D decision-makers with a mix of editorial content, sponsored resources, and events.
• Pharmaceutical Technology: B2B trade publication covering pharmaceutical development, manufacturing, and drug discovery technologies; directly comparable in editorial scope and advertiser base, particularly for tools/services and CRO/CDMO sponsors relevant to DDW.
• Fierce Biotech: B2B pharma/biotech publication (part of the Questex Fierce Pharma network) covering drug development news for industry professionals; directly comparable news/content format and advertising-supported model targeted at the same pharma audience.
• Outsourced Pharma: B2B media outlet focused on outsourced services and partnerships across drug development (CRO/CDMO/manufacturing); relevant peer to DDW because it covers overlapping drug-discovery and development topics for the same type of pharma/biopharma readers and advertisers.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/drugdiscoveryworld

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Drug Discovery World